Summary
Updated Aug 30, 2026
TAKEDA PHARMACEUTICAL CO LTD is 10% Owner of HilleVax, Inc. (HLVX). 1 SEC Form 4 filing on record, dated 17 September 2025.
Recent Transactions
1Every recent SEC Form 4 transaction TAKEDA PHARMACEUTICAL CO LTD has reported, most recent first.
Other Insiders Active in the Same Sector
No other insider has filed at TAKEDA PHARMACEUTICAL CO LTD's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- Ronda E. Stryker - $580.89M of SYK open-market activity in the last 12 months
- Keith A. Meister - $533.93M of ILMN open-market activity in the last 12 months
- TPG GP A, LLC - $516.71M of LFST open-market activity in the last 12 months
- BERKSHIRE HATHAWAY INC - $473.67M of DVA open-market activity in the last 12 months
- Fairmount Funds Management LLC - $399.66M of SYRE open-market activity in the last 12 months
- Robert M. Williams Jr. - $371.84M of AVAH open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
What is TAKEDA PHARMACEUTICAL CO LTD?
TAKEDA PHARMACEUTICAL CO LTD is a corporate entity, tracked as 10% Owner of HilleVax, Inc. (HLVX). InsiderAlpha holds 1 primary Form 4 filing for it, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did TAKEDA PHARMACEUTICAL CO LTD last file a Form 4?
The only primary Form 4 on record is dated 17 September 2025.
Where can I see all of TAKEDA PHARMACEUTICAL CO LTD's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow TAKEDA PHARMACEUTICAL CO LTD and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
